Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Asset Utilization Ratio: 2022-2025

Historic Asset Utilization Ratio for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to 68.20.

  • Molecular Partners Ag's Asset Utilization Ratio rose 29.60% to 68.20 in Q3 2025 from the same period last year, while for Sep 2025 it was 68.20, marking a year-over-year increase of 29.60%. This contributed to the annual value of 28.17 for FY2024, which is 11.37% down from last year.
  • Per Molecular Partners Ag's latest filing, its Asset Utilization Ratio stood at 68.20 for Q3 2025, which was up 5.76% from 64.48 recorded in Q2 2025.
  • Molecular Partners Ag's 5-year Asset Utilization Ratio high stood at 783.17 for Q3 2023, and its period low was 33.38 during Q2 2022.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 52.62 (2024), whereas its average is 242.31.
  • Over the last 5 years, Molecular Partners Ag's Asset Utilization Ratio had its largest YoY gain of 2,167.55% in 2023, and its largest YoY loss of 94.89% in 2023.
  • Molecular Partners Ag's Asset Utilization Ratio (Quarterly) stood at 698.72 in 2022, then tumbled by 94.89% to 35.68 in 2023, then rose by 15.34% to 41.16 in 2024, then grew by 29.60% to 68.20 in 2025.
  • Its Asset Utilization Ratio stands at 68.20 for Q3 2025, versus 64.48 for Q2 2025 and 43.71 for Q1 2025.